2017
A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease
Osibogun O, Ogunmoroti O, Michos ED, Spatz ES, Olubajo B, Nasir K, Maziak W. A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease. Reviews In Medical Virology 2017, 28 PMID: 29135056, DOI: 10.1002/rmv.1953.Peer-Reviewed Original ResearchConceptsHIV/HCV coinfectionCarotid intima-media thicknessHuman immunodeficiency virusC-reactive proteinHCV coinfectionHealthy controlsCoinfected individualsCVD biomarkersEndothelial markersHepatitis C virus coinfectionBiomarkers of CVDC virus coinfectionCardiovascular disease riskIntima-media thicknessSignificant lower levelsWeb of ScienceHCV monoinfectionCVD riskVirus coinfectionImmunodeficiency virusProspective studyIL-6Clinical trialsCardiovascular diseaseCarotid plaquesHIV/HCV coinfection and the risk of cardiovascular disease: A meta‐analysis
Osibogun O, Ogunmoroti O, Michos E, Spatz E, Olubajo B, Nasir K, Madhivanan P, Maziak W. HIV/HCV coinfection and the risk of cardiovascular disease: A meta‐analysis. Journal Of Viral Hepatitis 2017, 24: 998-1004. PMID: 28502092, DOI: 10.1111/jvh.12725.Peer-Reviewed Original ResearchConceptsHIV/HCV coinfectionHCV coinfectionHazard ratioCardiovascular diseaseHIV monoinfectionCVD riskHepatitis C virus coinfectionTraditional CVD risk factorsC virus coinfectionImproved antiretroviral therapyAdjusted hazard ratioCVD risk factorsRisk reduction therapyCongestive heart failureCoronary artery diseaseHuman immunodeficiency virusIncreased inflammatory responseRandom-effects modelWeb of ScienceHCV individualsAntiretroviral therapyCohort studyCVD outcomesArtery diseaseHeart failure
2015
One‐year outcomes of an intense workplace cardio‐metabolic risk reduction program among high‐risk employees: The My Unlimited Potential
Rouseff M, Aneni EC, Guzman H, Das S, Brown D, Osondu CU, Spatz E, Shaffer B, Santiago-Charles J, Ochoa T, Mora J, Gilliam C, Lehn V, Sherriff S, Tran TH, Post J, Veledar E, Feldman T, Agatston AS, Nasir K. One‐year outcomes of an intense workplace cardio‐metabolic risk reduction program among high‐risk employees: The My Unlimited Potential. Obesity 2015, 24: 71-78. PMID: 26637983, DOI: 10.1002/oby.21324.Peer-Reviewed Original ResearchConceptsBody mass indexDiastolic blood pressureSystolic blood pressureCardio-metabolic risk factorsMean body mass indexHigh-risk employeesBlood pressureRisk factorsHigh-sensitivity C-reactive proteinHigh cardiovascular disease riskCardio-metabolic outcomesPoor BP controlBaptist Health South FloridaLifestyle change programLifestyle intervention programOne-year outcomesCardiovascular disease riskC-reactive proteinBP controlCVD riskRisk reduction programsSerum lipidsHemoglobin A1cTotal cholesterolMass index